We further validated the role of DDX42 and GRB2 in cell proliferation, and radio‐ and sorafenib resistance in HCC cells via clonogenic, CCK‐8, and EdU assays, and identified their potential downstream PI3K/AKT signalling pathways. Here, AKT1 is linked to hepatocellular carcinoma.